Literature DB >> 8196267

Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule.

A J Bleyer1, P Fumo, E R Snipes, S Goldfarb, D A Simmons, F N Ziyadeh.   

Abstract

The polyol pathway in diabetes is activated in tissues that are not dependent on insulin for glucose uptake. To examine the role of the polyol pathway in renal extracellular matrix accumulation, we incubated murine proximal tubule cells in either normal or high glucose concentration in the presence or absence of the aldose reductase inhibitor sorbinil. Rising medium glucose from 100 to 450 mg/dl for 72 hours increased cell sorbitol levels sevenfold. Addition of 0.4 mM sorbinil reduced sorbitol content to virtually undetectable levels as measured by gas chromatography. Sorbinil (0.1 to 0.2 mM) also reduced the secretion of collagens types IV and I in the high glucose concentration after 48 to 72 hours but had no appreciable effect in the normal glucose concentration. Concordantly, 0.1 mM sorbinil inhibited the high glucose-induced stimulation of alpha 1(IV) and alpha 2(I) mRNA levels without affecting levels in normal glucose concentration. To study the role of transcriptional activation of collagen genes, we transfected proximal tubule cells with a chloramphenicol acetyltransferase (CAT) reporter gene linked to the promoter and regulatory elements of alpha 1(IV) gene. CAT activity increased several-fold in the cells grown in the high versus normal glucose concentration; this transcriptional activation in culture media containing high glucose concentration was reduced by treatment of the cells with 0.1 mM sorbinil. Thus, high ambient glucose activates the polyol pathway in proximal tubule cells, and may mediate the high glucose-induced stimulation of gene expression for collagens types IV and I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196267     DOI: 10.1038/ki.1994.88

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion.

Authors:  Guillermo Petrini; Elena J Ochoa; Esteban Serra; Adriana M Torres; M Monica Elías
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

2.  Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose.

Authors:  A Bakillah; A M Grigorova-Borsos; R Guillot; P Urios; M Sternberg
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

3.  Polarity of stimulation and secretion of transforming growth factor-beta 1 by cultured proximal tubular cells.

Authors:  A O Phillips; R Steadman; K Morrisey; J D Williams
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Authors:  F N Ziyadeh; B B Hoffman; D C Han; M C Iglesias-De La Cruz; S W Hong; M Isono; S Chen; T A McGowan; K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Identification of a renal-specific oxido-reductase in newborn diabetic mice.

Authors:  Q Yang; B Dixit; J Wada; Y Tian; E I Wallner; S K Srivastva; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 6.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 7.  The role of renal proximal tubular cells in diabetic nephropathy.

Authors:  Aled O Phillips
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

8.  Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury.

Authors:  Heba El Gamal; Ali Hussein Eid; Shankar Munusamy
Journal:  Biomed Res Int       Date:  2017-03-12       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.